BMJ 342:d2040 doi:10 ​1136/​bmj ​d2040 PubMedCrossRef 9 Bolland

BMJ 342:d2040. doi:10.​1136/​bmj.​d2040 PubMedCrossRef 9. Bolland MJ, Grey A, Gamble GD, Reid IR (2011) Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women’s Health Initiative (WHI) limited-access dataset. Am J Clin Nutr 94:1144–1149PubMedCrossRef 10. Chlebowski RT, Pettinger M, Kooperberg C (2011) Caution in reinterpreting the Women’s Health Initiative (WHI) calcium and vitamin MI-503 nmr D trial breast cancer results. Am J Clin Nutr. doi:3945/​ajcn.​111.​027664 11. Iso H, Stampfer MJ, Manson JE, Rexrode

K, Hennekens CH, Colditz GA, Speizer FE, Willett WC (1999) Prospective study of calcium, potassium and magnesium intake and risk of stroke in women. Stroke 30:1772–1779PubMedCrossRef 12. Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR (1999) Relation of calcium, vitamin D and dairy food intake to ischemic heart

disease mortality among postmenopausal women. Am J Epidemiol 149:151–161PubMedCrossRef 13. Al-Delaimy WK, Rimm E, Willett WC, Stampfer MJ, Hu FB (2003) A prospective study of calcium intake from diet and supplements and risk of ishemic heart disease among men. Am J Clin Nutr 77:814–818PubMed 14. Ascherio A, Rimm EB, Hernán MA, Giovannucci EL, Kawachi I, Stampfer MJ, Willett WC (1998) Intake of potassium, magnesium, calcium and fiber and risk of stroke among US men. Circulation 98:1198–1204PubMedCrossRef 15. Kuanrong L, Kaaks R, Linseisen J, Rohrmann S (2011) Associations of dietary calcium intake and calcium supplementation with VRT752271 myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Protirelin Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart 98:920–925 16. Neuhouser ML (2003) Dietary supplement use by American women: challenges in assessing patterns of use, motives

and costs. J Nutr 133:1992S–1996SPubMed 17. Neuhouser ML, Patterson RE, Levy L (1999) Motivations for using vitamin and mineral supplements. J Am Diet Assoc 99:851–854PubMedCrossRef 18. Prentice RL, Langer R, Stefanick M, Howard B, Pettinger M, Anderson G, Barad D, Curb D, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, for the Women’s Health Initiative Investigators (2005) Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between Women’s Health Initiative Clinical Trial and Observational Study Results. Am J Epidemiol 162:404–414PubMedCrossRef 19. Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, for the Women’s Health Initiative Investigators (2006) Combined analysis of Women’s Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>